Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 12, 2020American Journal of TransplantationOpen Access

Use of tocilizumab in kidney transplant recipients with COVID-19

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMaría José Pérez‐SáezMBMiquel BlascoDRDolores Redondo‐Pachón

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pérez‐Sáez et al. (2020) studied this question.

synapsesocial.com/papers/6a8d900db4e2d843785bebd6https://doi.org/10.1111/ajt.16192
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tocilizumab treatment in COVID‐19: A single center experience2020 · 1,291 citations
  2. 2Compassionate Use of Remdesivir for Patients with Severe Covid-192020 · 2,909 citations
  3. 3COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine2020 · 97 citations